Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis

Bavand Bikdeli; Renuka Visvanathan; David Jimenez; Manuel Monreal; Samuel Z. Goldhaber; Behnood Bikdeli

doi:10.1055/s-0039-1693464

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2019; 119(10): 1686-1694
DOI: 10.1055/s-0039-1693464

Stroke, Systemic or Venous Thromboembolism

Georg Thieme Verlag KG Stuttgart · New York

Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis

Authors

Bavand Bikdeli

¹Aged & Extended Care Services, The Queen Elizabeth Hospital, Adelaide, Australia

²Adelaide Geriatrics Training and Research with Aged Care (GTRAC) Centre, School of Medicine, Faculty of Health and Medical Science, University of Adelaide, Adelaide, Australia

³Division of Medical Sub-specialties, Lyell McEwin Hospital, Adelaide, Australia
Renuka Visvanathan

¹Aged & Extended Care Services, The Queen Elizabeth Hospital, Adelaide, Australia

²Adelaide Geriatrics Training and Research with Aged Care (GTRAC) Centre, School of Medicine, Faculty of Health and Medical Science, University of Adelaide, Adelaide, Australia
David Jimenez

⁴Respiratory and Medicine Department, Hospital Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain
Manuel Monreal

⁵Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona

⁶Universidad Católica de Murcia, Murcia, Spain
Samuel Z. Goldhaber

⁷Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States
Behnood Bikdeli

⁵Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona

⁸Division of Cardiology, Department of Medicine, Columbia University Medical Center/NewYork–Presbyterian Hospital, New York, New York, United States

⁹Center for Outcomes Research & Evaluation, Yale New Haven Hospital, New Haven, Connecticut, United States

Abstract

Although prophylaxis for venous thromboembolism (VTE) is recommended after many surgeries, evidence base for use of VTE prophylaxis after foot or ankle surgery has been elusive, leading into varying guidelines recommendations and notable practice variations. We conducted a systematic review of the literature to determine if use of VTE prophylaxis decreased the frequency of subsequent VTE, including deep vein thrombosis (DVT) or pulmonary embolism (PE), compared with control. We searched PubMed, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov through May 2018, for randomized controlled trials (RCTs) or prospective controlled observational studies of VTE prophylaxis in patients undergoing foot and ankle surgery. Our search retrieved 263 studies, of which 6 were finally included comprising 1,600 patients. Patients receiving VTE prophylaxis had lower risk for subsequent DVT (risk ratio [RR]: 0.72; 95% confidence interval [CI]: 0.55–0.94) and subsequent VTE (RR: 0.72; 95% CI: 0.55–0.94). There was only one case of nonfatal PE, no cases of fatal PE, and no change in all-cause mortality (RR: 3.51; 95% CI: 0.14–84.84). There was no significant difference in the risk for bleeding (RR: 2.12; 95% CI: 0.53–8.56). Very few RCTs exist regarding the efficacy and safety of VTE prophylaxis in foot and ankle surgery. Prophylaxis appears to reduce the risk of subsequent VTE, but the event rates are low and symptomatic events are rare. Future studies should determine the subgroups of patients undergoing foot or ankle surgery in whom prophylaxis may be most useful.

Keywords

venous thromboembolism - foot or ankle surgery - prophylaxis - systematic review - meta-analysis

Volltext

Referenzen

References
1 Gordon RJ, Lombard FW. Perioperative venous thromboembolism: a review. Anesth Analg 2017; 125 (02) 403-412
2 Laryea J, Champagne B. Venous thromboembolism prophylaxis. Clin Colon Rectal Surg 2013; 26 (03) 153-159
3 Minges KE, Bikdeli B, Wang Y. , et al. National trends in pulmonary embolism hospitalization rates and outcomes for adults aged ≥65 years in the United States (1999 to 2010). Am J Cardiol 2015; 116 (09) 1436-1442
4 Engbers MJ, van Hylckama Vlieg A, Rosendaal FR. Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 2010; 8 (10) 2105-2112
5 Gould MK, Garcia DA, Wren SM. , et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e227S-e277S
6 Falck-Ytter Y, Francis CW, Johanson NA. , et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e278S-e325S
7 Lee DK, Mulder GD. Foot and ankle surgery: considerations for the geriatric patient. J Am Board Fam Med 2009; 22 (03) 316-324
8 Mizel MS, Temple HT, Michelson JD. , et al. Thromboembolism after foot and ankle surgery. A multicenter study. Clin Orthop Relat Res 1998; (348) 180-185
9 Saragas NP, Ferrao PN, Jacobson BF, Saragas E, Strydom A. The benefit of pharmacological venous thromboprophylaxis in foot and ankle surgery. S Afr Med J 2017; 107: 327-330
10 Makhdom AM, Cota A, Saran N, Chaytor R. Incidence of symptomatic deep venous thrombosis after Achilles tendon rupture. J Foot Ankle Surg 2013; 52 (05) 584-587
11 Nilsson-Helander K, Thurin A, Karlsson J, Eriksson BI. High incidence of deep venous thrombosis after Achilles tendon rupture: a prospective study. Knee Surg Sports Traumatol Arthrosc 2009; 17 (10) 1234-1238
12 Patel A, Ogawa B, Charlton T, Thordarson D. Incidence of deep vein thrombosis and pulmonary embolism after Achilles tendon rupture. Clin Orthop Relat Res 2012; 470 (01) 270-274
13 National Clinical Guideline Centre–Acute and Chronic Conditions (UK). Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted to Hospital. London: Royal College of Physicians (UK); 2010. National Institute for Health and Clinical Excellence: Guidance
14 Fletcher J, Baker R, MacLellan D, et al. Australia and New Zealand Working Party on the Management and Prevention of Venous thromboembolism. Prevention of venous thromboembolism: best practice guidelines for Australia and New Zealand. 4th ed. Sydney: Health Education and Management Innovations; 2007
15 Fleischer AE, Abicht BP, Baker JR, Boffeli TJ, Jupiter DC, Schade VL. American College of Foot and Ankle Surgeons' clinical consensus statement: risk, prevention, and diagnosis of venous thromboembolism disease in foot and ankle surgery and injuries requiring immobilization. J Foot Ankle Surg 2015; 54 (03) 497-507
16 Wolf JM, DiGiovanni CW. A survey of orthopedic surgeons regarding DVT prophylaxis in foot and ankle trauma surgery. Orthopedics 2004; 27 (05) 504-508
17 Domeij-Arverud E, Labruto F, Latifi A, Nilsson G, Edman G, Ackermann PW. Intermittent pneumatic compression reduces the risk of deep vein thrombosis during post-operative lower limb immobilisation: a prospective randomised trial of acute ruptures of the Achilles tendon. Bone Joint J 2015; 97-B: (05) 675-680
18 Selby R, Geerts WH, Kreder HJ, Crowther MA, Kaus L, Sealey F. ; D-KAF (Dalteparin in Knee-to-Ankle Fracture) Investigators. A double-blind, randomized controlled trial of the prevention of clinically important venous thromboembolism after isolated lower leg fractures. J Orthop Trauma 2015; 29 (05) 224-230
19 Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med 2009; 151 (04) 264-269
20 Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I9-I16
21 Yhim HY, Jang MJ, Bang SM. , et al. Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. J Thromb Haemost 2014; 12 (07) 1035-1043
22 Menz HB, Gilheany MF, Landorf KB. Foot and ankle surgery in Australia: a descriptive analysis of the Medicare Benefits Schedule database, 1997-2006. J Foot Ankle Res 2008; 1 (01) 10
23 Higgins JP, Altman DG, Gøtzsche PC. , et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928
24 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21 (11) 1539-1558
25 Lassen MR, Borris LC, Nakov RL. Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization. N Engl J Med 2002; 347 (10) 726-730
26 Goel DP, Buckley R, deVries G, Abelseth G, Ni A, Gray R. Prophylaxis of deep-vein thrombosis in fractures below the knee: a prospective randomised controlled trial. J Bone Joint Surg Br 2009; 91 (03) 388-394
27 Lapidus LJ, Ponzer S, Elvin A. , et al. Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized placebo-controlled, double-blind study. Acta Orthop 2007; 78 (04) 528-535
28 Lapidus LJ, Rosfors S, Ponzer S. , et al. Prolonged thromboprophylaxis with dalteparin after surgical treatment of Achilles tendon rupture: a randomized, placebo-controlled study. J Orthop Trauma 2007; 21 (01) 52-57
29 Zheng X, Li DY, Wangyang Y. , et al. Effect of chemical thromboprophylaxis on the rate of venous thromboembolism after treatment of foot and ankle fractures. Foot Ankle Int 2016; 37 (11) 1218-1224
30 Budhiparama NC, Abdel MP, Ifran NN, Parratte S. Venous thromboembolism (VTE) prophylaxis for hip and knee arthroplasty: changing trends. Curr Rev Musculoskelet Med 2014; 7 (02) 108-116
31 Zee AA, van Lieshout K, van der Heide M, Janssen L, Janzing HM. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization. Cochrane Database Syst Rev 2017; 8: CD006681
32 Galanaud JP, Sevestre-Pietri MA, Bosson JL. , et al; OPTIMEV-SFMV Investigators. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study. Thromb Haemost 2009; 102 (03) 493-500
33 Robert-Ebadi H, Righini M. Management of distal deep vein thrombosis. Thromb Res 2017; 149: 48-55
34 Righini M. Is it worth diagnosing and treating distal deep vein thrombosis? No. J Thromb Haemost 2007; 5 (Suppl. 01) 55-59
35 Calder JD, Freeman R, Domeij-Arverud E, van Dijk CN, Ackermann PW. Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery. Knee Surg Sports Traumatol Arthrosc 2016; 24 (04) 1409-1420
36 Brateanu A, Patel K, Chagin K. , et al. Probability of developing proximal deep-vein thrombosis and/or pulmonary embolism after distal deep-vein thrombosis. Thromb Haemost 2016; 115 (03) 608-614
37 Hickey BA, Cleves A, Alikhan R, Pugh N, Nokes L, Perera A. The effect of active toe movement (AToM) on calf pump function and deep vein thrombosis in patients with acute foot and ankle trauma treated with cast - a prospective randomized study. Foot Ankle Surg 2017; 23 (03) 183-188
38 Blanco JA, Slater G, Mangwani J. A prospective cohort study of symptomatic venous thromboembolic events in foot and ankle trauma: the need for stratification in thromboprophylaxis?. J Foot Ankle Surg 2018; 57 (03) 484-488
39 Pitto RP, Young S. Foot pumps without graduated compression stockings for prevention of deep-vein thrombosis in total joint replacement: efficacy, safety and patient compliance. A comparative, prospective clinical trial. Int Orthop 2008; 32 (03) 331-336
40 Warwick D, Harrison J, Glew D, Mitchelmore A, Peters TJ, Donovan J. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial. J Bone Joint Surg Am 1998; 80 (08) 1158-1166
41 Jacobs JJ, Mont MA, Bozic KJ. , et al. American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am 2012; 94 (08) 746-747
42 Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. ; PREVENT Medical Thromboprophylaxis Study Group. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005; 93 (01) 76-79

Zusatzmaterial

Supplementary Material (PDF)